Product Code: SR112025A2160
The global bariatric surgery devices market size reached USD 3.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.6 Billion by 2033, exhibiting a growth rate (CAGR) of 4.4% during 2025-2033. The growing prevalence of several lifestyle disorders, such as diabetes, obesity, and cardiovascular diseases (CVDs), is stimulating the market.
Bariatric Surgery Devices Market Analysis:
- Major Market Drivers: The increasing prevalence of weight-related problems, owing to unhealthy dietary patterns, is propelling the market.
- Key Market Trends: The rising preferences for minimally invasive (MI) bariatric procedures and devices that eliminate the requirement for large incisions and cause minimal postoperative stress are bolstering the market.
- Competitive Landscape: Some of the prominent companies in the market include Apollo Endosurgery Inc., GI Dynamics, Intuitive Surgical Inc., Johnson & Johnson Services Inc., Medtronic Inc., Olympus Corporation, Reach Surgical Inc., Reshape Lifesciences Inc., Spatz Fgia Inc., TransEnterix Inc., and USGI Medical Inc., among many others.
- Geographical Trends: The growing adoption of surgical robots is fueling the market in North America. Besides this, the development of devices with minimal pain and enhanced cosmetic results is contributing to the regional market.
- Challenges and Opportunities: The high costs related to devices are hindering the market. However, the growing insurance coverage will continue to fuel the market in the coming years.
Bariatric Surgery Devices Market Trends:
Rising Incidences of Obesity
Due to hectic schedules and sedentary lifestyles, there is an escalating requirement for weight management practices, thereby highlighting the urgent need for medical solutions like bariatric surgery. Moreover, extensive investments in R&D activities to improve clinical outcomes are propelling the market. For instance, in April 2024, Phenomix Sciences launched a new MyPhenome test that identifies all three key obesity phenotypes in a single test.
Growing Integration of AI
Machine learning and AI are transforming the market by enabling smarter, data-driven surgical procedures. These technologies further aid in intraoperative guidance, preoperative planning, and postoperative monitoring, thereby enhancing the outcomes. In April 2024, Allurion Technologies, Inc. announced the commercial availability of its comprehensive Virtual Care Suite (VCS) powered by artificial intelligence (AI) in the United States. This is positively influencing the bariatric surgery devices market outlook.
Increasing Focus on Enhanced Procedures
The growing need to provide patients with safer options with faster recovery times is catalyzing the market. These techniques, such as gastric bypass and laparoscopic sleeve gastrectomy, involve small incisions and advanced tools like the Echelon Flex(TM) GST System from Ethicon. These innovations minimize surgical trauma and postoperative pain, thereby making the procedures more appealing to patients and surgeons alike.
Global Bariatric Surgery Devices Industry Segmentation:
Breakup by Procedure Type:
- Minimally Invasive Surgical Procedures
- Non-Invasive Surgical Procedures
Minimally invasive surgical procedures dominate the market
Minimally invasive surgical procedures improve patient outcomes. Medtronic's Hugo robotic-assisted surgery system is designed to accelerate recovery times. This is escalating the bariatric surgery devices market demand.
Breakup by Device Type:
- Assisting Devices
- Stapling Devices
- Energy Based Vessel Sealing Devices
- Suturing Devices
- Trocars
- Clip Appliers
- Others
- Implantable Devices
- Gastric Bands
- Electrical Stimulators
- Gastric Balloons
- Transpyloric Shuttle
- Others
Assisting devices (suturing devices) currently hold most of the total bariatric surgery devices market share
Assisting devices, particularly suturing devices, aid in improving surgical efficiency. Companies like Ethicon and Medtronic have been at the forefront of these innovations.
Breakup by Procedure:
- Sleeve Gastrectomy
- Adjustable Gastric Banding
- Roux-en-Y Gastric Bypass
- Biliopancreatic Diversion with Duodenal Switch
- Others
Roux-en-Y gastric bypass holds the majority of the global bariatric surgery devices market revenue
Roux-en-Y gastric bypass (RYGB) leads to significant weight loss and improved metabolic health. For instance, Ethicon's Echelon Circular Powered Stapler offers surgeons high precision during the anastomosis phase.
Breakup by Application:
- Weight Loss
- Hereditary Disease
- Other Disorders
Weight loss dominates the bariatric surgery devices market statistics
Bariatric surgery devices play a crucial role in facilitating weight loss. They include suturing tools, advanced staplers, and laparoscopic instruments.
Breakup by End-User:
- Bariatric Surgery Clinics
- Hospitals
- Others
Bariatric surgery clinics dominate the market
Bariatric surgery clinics improve patient care and outcomes. For instance, European Weight Loss Clinics integrated ORBERA(R) intragastric balloons, a non-surgical weight loss solution that assists patients in losing weight before or instead of surgery.
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
North America exhibits a clear dominance in the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
As per the bariatric surgery devices market overview, the widespread adoption of robotic-assisted surgery is acting as a significant growth-inducing factor. Moreover, the rising focus of individuals in weight management is also driving the regional market. As per the IMARC, the United States weight management market size reached US$ 78.5 Billion in 2023. Looking forward, IMARC Group projects the market to reach US$ 127.2 Billion by 2032, thereby exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.
Competitive Landscape:
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major bariatric surgery devices market companies have also been provided. Some of the key players in the market include:
- Apollo Endosurgery Inc.
- GI Dynamics
- Intuitive Surgical Inc.
- Johnson & Johnson Services Inc.
- Medtronic Inc.
- Olympus Corporation
- Reach Surgical Inc.
- Reshape Lifesciences Inc.
- Spatz Fgia Inc.
- TransEnterix Inc.
- USGI Medical Inc.
Key Questions Answered in This Report
- 1.How big is the global bariatric surgery devices market?
- 2.What is the expected growth rate of the global bariatric surgery devices market during 2025-2033?
- 3.What are the key factors driving the global bariatric surgery devices market?
- 4.What has been the impact of COVID-19 on the global bariatric surgery devices market?
- 5.What is the breakup of the global bariatric surgery devices market based on the procedure type?
- 6.What is the breakup of the global bariatric surgery devices market based on the device type?
- 7.What is the breakup of the global bariatric surgery devices market based on the procedure?
- 8.What is the breakup of the global bariatric surgery devices market based on the application?
- 9.What is the breakup of the global bariatric surgery devices market based on the end user?
- 10.What are the key regions in the global bariatric surgery devices market?
- 11.Who are the key players/companies in the global bariatric surgery devices market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Bariatric Surgery Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Procedure Type
- 6.1 Minimally Invasive Surgical Procedures
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Non-Invasive Surgical Procedures
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Device Type
- 7.1 Assisting Devices
- 7.1.1 Market Trends
- 7.1.2 Major Types
- 7.1.2.1 Stapling Devices
- 7.1.2.2 Energy Based Vessel Sealing Devices
- 7.1.2.3 Suturing Devices
- 7.1.2.4 Trocars
- 7.1.2.5 Clip Appliers
- 7.1.2.6 Others
- 7.1.3 Market Forecast
- 7.2 Implantable Devices
- 7.2.1 Market Trends
- 7.2.2 Major Types
- 7.2.2.1 Gastric Bands
- 7.2.2.2 Electrical Stimulators
- 7.2.2.3 Gastric Balloons
- 7.2.2.4 Transpyloric Shuttle
- 7.2.2.5 Others
- 7.2.3 Market Forecast
8 Market Breakup by Procedure
- 8.1 Sleeve Gastrectomy
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Adjustable Gastric Banding
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Roux-en-Y Gastric Bypass
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Biliopancreatic Diversion with Duodenal Switch
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Application
- 9.1 Weight Loss
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Hereditary Disease
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Other Disorders
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by End-User
- 10.1 Bariatric Surgery Clinics
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Hospitals
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Others
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.2 Asia Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Indicators
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 Apollo Endosurgery Inc.
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.1.3 Financials
- 16.3.1.4 SWOT Analysis
- 16.3.2 GI Dynamics
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.2.3 Financials
- 16.3.3 Intuitive Surgical Inc.
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.3.3 Financials
- 16.3.3.4 SWOT Analysis
- 16.3.4 Johnson & Johnson Services Inc.
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.5 Medtronic Inc.
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.6 Olympus Corporation
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.6.3 Financials
- 16.3.6.4 SWOT Analysis
- 16.3.7 Reach Surgical Inc.
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.8 Reshape Lifesciences Inc.
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.8.3 Financials
- 16.3.9 Spatz Fgia Inc.
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.10 TransEnterix Inc.
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.10.3 Financials
- 16.3.11 USGI Medical Inc.
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio